|
| Exchange Disseminated Time | Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release dated January 11, 2012 regarding an agreement with Phafag AG, Switzerland.
Press Release:
"Lincoln Pharmaceuticals Ltd (LPL), a world class pharmaceutical Company had entered into an agreement with Phafag AG, Switzerland, for its Carovenne molecule for the treatment of Tinnitus - commonly known as "ringing in the ear" a condition where the inner hair cells get damaged causing continuous depression, anxiety and insomnia m patients. Millions of people around the world-suffer from Tinnitus. LPL became the first Company in India to introduce a cure for Tinnitus as TINNEX injection using Caroverine." (For more details kindly refer Corporate Announcements on www.bseindia.com). |
|
|